Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Axplora Announces €6.5 Million Investment at Vizag Site | Contract Pharma

What are you searching for?

Sign in
Breaking News

Axplora Announces €6.5 Million Investment at Vizag Site

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ingredients.

By: Rachel Klemovitch

Assistant Editor

Axplora, a global provider of API small molecule manufacturing, announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience. This announcement follows the successful completion of routine U.S. FDA inspections in 2025 at both of Axplora’s Indian manufacturing sites, Vizag and Chennai, which form part of the company’s PharmaZell Business Unit. 

The expansion project at Vizag will increase output and create new employment opportunities, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ingredients.

The Vizag and Chennai sites completed routine inspections by the U.S. FDA in 2025, each concluding with a Voluntary Action Indicated (VAI) classification. 

The inspector at the Chennai facility highlighted the strong and consistent implementation of current Good Manufacturing Practices (cGMP), streamlined and efficient document management and retrieval processes, and the standards maintained in facility upkeep and overall site hygiene.

With enhanced capacity at Vizag and regulatory compliance across both sites, Axplora continues to solidify its presence in India and its role as a partner for the global pharmaceutical industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics